According to a new study, hidradenitis suppurativa (HS) comorbidity burden and healthcare resource utilizations costs continue to increase after diagnosis.
top of page
it's where dermatology lives
bottom of page
According to a new study, hidradenitis suppurativa (HS) comorbidity burden and healthcare resource utilizations costs continue to increase after diagnosis.
Comments